SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017279
Filing Date
2022-08-15
Accepted
2022-08-15 11:34:49
Documents
112
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gls-20220630.htm   iXBRL 10-Q 4333535
2 EX-31.1 gls-ex31_1.htm EX-31.1 19166
3 EX-31.2 gls-ex31_2.htm EX-31.2 22433
4 EX-32.1 gls-ex32_1.htm EX-32.1 13895
5 EX-32.2 gls-ex32_2.htm EX-32.2 13889
  Complete submission text file 0000950170-22-017279.txt   15304210

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20220630.xsd EX-101.SCH 110819
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gls-20220630_def.xml EX-101.DEF 435745
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20220630_pre.xml EX-101.PRE 609340
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20220630_lab.xml EX-101.LAB 739500
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gls-20220630_cal.xml EX-101.CAL 78419
106 EXTRACTED XBRL INSTANCE DOCUMENT gls-20220630_htm.xml XML 2868720
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39362 | Film No.: 221163709
SIC: 2834 Pharmaceutical Preparations